A Randomized, Parallel Group, Open Label, Active Controlled Clinical Study to evaluate the Efficacy and Safety of a Polyherbal Unani Formulation in the Management of Waram TajaÌ?wiÌ?f al-Anf Muzmin (Chronic Sinusitis)

ational Research Institute of Unani Medicine for Skin Disorders, Hyederabad0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1. Duration of the disease >12 week.
•2. Patient having at least two out of four cardinal symptoms (i.e., facial
•pain/pressure, hyposmia/anosmia, nasal obstruction, and nasal discharge
•for at least 12 consecutive weeks.
•3. Patient having other symptoms rhinorrhea, nasal congestion, frontal headache, nasal itching, impaired sense of smell and frequent sneezing for more than 12 weeks.
•4. Positive X-ray PNS finding (Thickened mucosal lining, opacity of sinus).

•1. Patient aged < 18 years or >50 years.
•2. Patient with deviated nasal septum(DNS).
•3. Local pathology such as mucocele, cyst, antrochoanal polyp, facial trauma.
•4. Diabetes mellitus and any other illness requiring long term treatment.
•5. Pregnant or Lactating Women.
•6. Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
•7. Known cases of Immunocompromised states (HIV/ AIDS, etc.)/Malignancies.
•8. Patient not willing to attend regular treatment and follow-up for the entire duration of study.
•9. Mentally retarded patients.
•10.Patient having history of any surgery of nose or paranasal sinuses.
•11. Patient having history of trauma to nose or sinus area.
•12. Patient of pulmonary Kochâ??s or having history of epistaxis.
•13. Any medical condition where physician feels that participation in the study could be detrimental to patientâ??s well being.
•14. Alcoholic and Drug addicted patient.
•15. Patient having allergy of controlled drug or with any of the ingredients of test drug.

发起方

ational Research Institute of Unani Medicine for Skin Disorders, Hyederabad